As of 2025-12-22, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 80.96 USD. This relative valuation is based on P/E multiples. With the latest stock price at 145.00 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is -44.2%.
The range of the Relative Valuation is 75.55 - 99.27 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 21.6x | 17.6x |
| Forward P/E multiples | 20.7x - 24.0x | 20.9x |
| Fair Price | 75.55 - 99.27 | 80.96 |
| Upside | -47.9% - -31.5% | -44.2% |
| Date | P/E |
| 2025-12-19 | 33.78 |
| 2025-12-18 | 33.04 |
| 2025-12-17 | 33.01 |
| 2025-12-16 | 34.65 |
| 2025-12-15 | 35.89 |
| 2025-12-12 | 35.60 |
| 2025-12-11 | 36.05 |
| 2025-12-10 | 36.26 |
| 2025-12-09 | 36.11 |
| 2025-12-08 | 36.11 |
| 2025-12-05 | 36.23 |
| 2025-12-04 | 35.93 |
| 2025-12-03 | 35.40 |
| 2025-12-02 | 35.52 |
| 2025-12-01 | 35.15 |
| 2025-11-28 | 35.45 |
| 2025-11-26 | 35.31 |
| 2025-11-25 | 33.44 |
| 2025-11-24 | 32.91 |
| 2025-11-21 | 33.04 |
| 2025-11-20 | 32.38 |
| 2025-11-19 | 32.16 |
| 2025-11-18 | 32.30 |
| 2025-11-17 | 33.44 |
| 2025-11-14 | 33.75 |
| 2025-11-13 | 33.59 |
| 2025-11-12 | 34.21 |
| 2025-11-11 | 34.31 |
| 2025-11-10 | 34.95 |
| 2025-11-07 | 35.50 |
| 2025-11-06 | 36.06 |
| 2025-11-05 | 35.82 |
| 2025-11-04 | 33.36 |
| 2025-11-03 | 33.07 |
| 2025-10-31 | 33.36 |
| 2025-10-30 | 32.16 |
| 2025-10-29 | 32.15 |
| 2025-10-28 | 34.33 |
| 2025-10-27 | 34.70 |
| 2025-10-24 | 33.55 |
| 2025-10-23 | 33.47 |
| 2025-10-22 | 32.96 |
| 2025-10-21 | 33.23 |
| 2025-10-20 | 32.93 |
| 2025-10-17 | 32.64 |
| 2025-10-16 | 32.04 |
| 2025-10-15 | 32.09 |
| 2025-10-14 | 31.97 |
| 2025-10-13 | 32.00 |
| 2025-10-10 | 31.83 |